I will be initiating a project to study therapeutic effects of immune engagers on breast cancer. If I want to study therapeutic effects of immune engagers against breast cancer, is it better to use an ectopic tumor mouse models or is it better to use breast cancer organoids? Can anyone tell me the best commercial source of liver cancer organoids and is ATCC a good option?

More Dirghau Manishbhai Patel's questions See All
Similar questions and discussions